PREVENTION OF ADENOVIRAL EYE INFECTION - REVIEW

Katarina Mirjane Janicijevic, Sanja Kocic, Snezana Radovanovic, Svetlana Radevi?, Dragan Vasiljevic, Nela Djonovic, Tatjana Sarenac Vulovic

Abstract


Epidemic viral conjunctivitis caused by adenovirus is the most common infectious conjunctivitis. The exact incidence of adenoviral conjunctivitis is still poorly known, but there are two well-defined adenoviral keratoconjunctivitis clinical syndromes: epidemic keratoconjunctivitis (EKC) and pharyngoconjunctival fever (PCF). Epidemic keratoconjunctivitis is also the most severe form and presents with watery discharge, hyperemia, chemosis and ipsilateral lymphadenopathy. Diagnosis is mainly clinical, but its etiology can be confirmed using cell cultures, antigen detection, polymerase chain reaction or immune-chromatography. Multiple treatments have been tried for this disease, but none of them seem to be completely effective. Viruses are resistant to desiccation and certain common surface disinfectants. Prevention is the most reliable and recommended strategy to control this epidemic infection. Global epidemic surveillance system definitely needs to be established to monitor and analyze the epidemic conjunctivitis in the future. There is clearly a need for the national and the military public health institutions to work together on guidelines to handle future challenges.


Keywords


epidemic, adenoviral, conjunctivitis, keratitis, diagnosis, therapy, prevention

Full Text:

PDF

References


Zhang L, Zhao N, Sha J, Wang C, Jin X, Amer S, et al. Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013. Epidemiol Infect. 2016; 144(8): 1661-72.

Chang CH, Lin KH, Sheu MM, Huang WL, Wang HZ, Chen CW. The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan. Graefes Arch Clin Exp Ophthalmol. 2003; 241(7): 554-60.

Pleyer U, Birnbaum F. Adenoviral keratoconjunctivitis. Ophthalmologe. 2015; 112(5): 459-69.

Ghebremedhin B. Human adenovirus: Viral pathogen with increasing importance. Eur J Microbiol Immunol (Bp). 2014; 4(1): 26-33.

González-López JJ, Morcillo-Laiz R, Muñoz-Negrete FJ. Adenoviral keratoconjunctivitis: an update. Arch Soc Esp Oftalmol. 2013; 88(3): 108-15.

Renard G. Adenoviral keratoconjunctivitis. J Fr Ophtalmol. 2010; 33(8): 586-92.

Mochizuki K, Katada T, Ohkusu K, Kaneko H. Three cases of acute conjunctivitis caused by human adenovirus in medical workers. Kansenshogaku Zasshi. 2010; 84(4): 469-73.

Doyle TJ, King D, Cobb J, Miller D, Johnson B. An outbreak of epidemic keratoconjunctivitis at an outpatient ophthalmology clinic. Infect Dis Rep. 2010; 2(2): e17.

Bialasiewicz A, Brehler R, Draeger J, Schmitz H. Mathematical modelling of epidemics under specific regard of adenoviral keratoconjunctivitis. Eur J Med Res. 2008; 13(8): 355-65.

Sendra-Gutiérrez JM, Martín-Rios D, Casas I, Sáez P, Tovar A, Moreno C. An outbreak of adenovirus type 8 keratoconjunctivitis in a nursing home in Madrid. Euro Surveill. 2004; 9(3): 27-30.

Shiota H, Ohno S, Aoki K, Azumi A, Ishiko H, Inoue Y, et al. Guideline for the nosocomial infections of adenovirus conjunctivitis. Nippon Ganka Gakkai Zasshi. 2009; 113(1): 25-46.

Ribeiro MM, Neumann VA, Padoveze MC, Graziano KU. Efficacy and effectiveness of alcohol in the disinfection of semi-critical materials: a systematic review. Rev Lat Am Enfermagem. 2015; 23(4): 741-52.

Koo D, Bouvier B, Wesley M, Courtright P, Reingold A. Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic; need for re-evaluation of the design and disinfection of instruments. Infect Control Hosp Epidemiol. 1989; 10(12): 547-52.

Hiti H, Hanselmayer H, Hofmann H. Experience in therapy and prophylaxis of epidemic keratoconjunctivitis (author's transl). Klin Monbl Augenheilkd. 1979; 174(3): 456-61.

Al-Siyabi T, Binkhamis K, Wilcox M, Wong S, Pabbaraju K, Tellier R, et al. A cost effective real-time PCR for the detection of adenovirus from viral swabs. Virol J. 2013; 10: 184.

Kuo IC, Espinosa C, Forman M, Valsamakis A. A polymerase chain reaction-based algorithm to detect and prevent transmission of adenoviral conjunctivitis in hospital employees. Am J Ophthalmol .2016; 163: 38-44.

Kuo IC, Espinosa C, Forman M, Pehar M, Maragakis LL, Valsamakis A. Detection and prevalence of adenoviral conjunctivitis among hospital employees using real-time polymerase chain reaction as an infection prevention tool. Infect Control Hosp Epidemiol. 2014; 35(6): 728-31.

Marangon FB, Miller D, Alfonso E. Laboratory results in ocular viral diseases: implications in clinical-laboratory correlation. Arq Bras Oftalmol. 2007; 70(2): 189-94.

Uchio E. New medical treatment for viral conjunctivitis. Nippon Ganka Gakkai Zasshi. 2005; 109(12): 962-84.

Rutala WA, Peacock JE, Gergen MF, Sobsey MD, Weber DJ. Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob Agents Chemother. 2006; 50(4): 1419-24.

Clement C, Capriotti JA, Kumar M, Hobden JA, Foster TP, Bhattacharjee PS et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-Iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2011; 52(1): 339–44.

Gleavy D. The nursing role in epidemiology, risk management, and patient-public education. J Ophthalmic Nurs Technol. 1990; 9(5): 215-9.

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 2001; 14(1): 227.

Aoki K, Benkö M, Davison AJ, Echavarria M, Erdman DD, Harrach B, et al. Members of the Adenovirus Research Community. Toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virology. J Virol. 2011; 85(11): 5703–4.

Nercelles MP, Peirano NL, Herrera OR, Rivero BP, Márquez PL. A nosocomial outbreak of epidemic keratoconjunctivitis. Rev Chilena Infectol. 2010; 27(6): 534-8.

Meyer-Rüsenberg B, Loderstädt U, Richard G, Kaulfers PM, Gesser C. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int. 2011; 108(27): 475-80.

Sehulster, L., R. Y. W. Chinn. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Morb. Mortal. Wkly. Rep. 2003; 52: 1-44.

Schrauder A, Altmann D, Laude G, Claus H, Wegner K, Köhler R, et al. Epidemic conjunctivitis in Germany, 2004. Euro Surveill. 2006; 11(7): 185-7.

Mema SC, MacDonald J, Wyse JP, Gonder T, Musto R, McIntyre L. Public Health adds value to an investigation of epidemic keratoconjunctivitis. Can J Ophthalmol. 2010; 45(5): 538.

Centers for Disease Control and Prevention (CDC). Adenovirus-associated epidemic keratoconjunctivitis outbreaks four states, 2008-2010. Morb Mortal Wkly Rep. 2013; 62(32): 637-41.

Omar Akhtar A, Singh H, Si F, Hodge WG. A systematic review and cost-effectiveness analysis of tonometer disinfection methods. Can J Ophthalmol. 2014; 49(4): 345-50.

Jhanji V, Chan TC, Li EY, Agarwal K, Vajpayee RB. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015; 60(5): 435-43.

Jani?ijevi? Petrovi? M, Sre?kovi? S, Petrovi? N, Šarenac T. Epidemijski keratokonjunktivitis. Srp Arh Celok Lek. 2011; 139(5-6): 282-5.

Massey J, Henry R, Minich L, Lamson DM, St George K. Notes from the field: health care-associated outbreak of epidemic keratoconjunctivitis West Virginia, 2015. Morb Mortal Wkly Rep. 2016; 65(14): 382-3.




DOI: http://dx.doi.org/10.24125/sanamed.v1i1.161

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Katarina Mirjane Janicijevic, Sanja Kocic, Snezana Radovanovic, Svetlana Radevi?, Nela Djonovic, Tatjana Sarenac Vulovic, Dragan Vasiljevic

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.